APO Research

APO RESEARCH · REPORT

Coronary Pathway Products

Selected research

Industry Growth & Trends

Global Coronary Pathway Products Industry Growth and Trends Forecast to 2032

Market perspective

According to APO Research, the global Coronary Pathway Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Coronary Pathway Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Coronary Pathway Products is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Coronary Pathway Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Coronary Pathway Products market include Medtronic, Terumo Corporation, Boston Scientific, Cordis, Abbott, Merit Medical, Curatia Medical, ASAHI INTECC and Zhejiang Barty Medical Technology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Coronary Pathway Products market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Coronary Pathway Products market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Coronary Pathway Products market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Coronary Pathway Products.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Coronary Pathway Products market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Coronary Pathway Products Market by Company

Medtronic

Terumo Corporation

Boston Scientific

Cordis

Abbott

Merit Medical

Curatia Medical

ASAHI INTECC

Zhejiang Barty Medical Technology

OrbusNeich Medical Company

MicroPort Scientific Corporation

Suzhou Innomed Medical Device

Shunmei Medical

Shenzhen MicroApproach Medical Technology

Shanghai INT Medical Instruments

Xiamen New Concept Medical Technology

Lepu Medical Technology

APT Medical

BrosMed Medical

Beijing Demax Medical Technology

Jiangsu ChangMei Medtech

Jiangxi Hongda Medical Equipment Group

Changzhou JIUHONG Medical Instrument

Coronary Pathway Products Segment by Type

Catheter Sheath Set

Arterial Compression Tourniquet

Balloon Dilation Pressure Pump

Microcatheter

Micro Guide Wire

Contrast Catheter

Contrast Guide Wire

Guiding Catheter

Y-Shaped Connector

Others

Coronary Pathway Products Segment by Application

Hospital

Clinic

Others

Coronary Pathway Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coronary Pathway Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coronary Pathway Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coronary Pathway Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Coronary Pathway Products companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Coronary Pathway Products Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Coronary Pathway Products Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Coronary Pathway Products Market Share by Region (2021-2026) Table 4. Global Coronary Pathway Products Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Coronary Pathway Products Market Share by Region (2027-2032) Table 6. Global Coronary Pathway Products Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Coronary Pathway Products Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Coronary Pathway Products Market Size Share by Type (2021-2026) Table 9. Global Coronary Pathway Products Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Coronary Pathway Products Market Size Share Forecasted by Type (2027-2032) Table 11. North America Coronary Pathway Products Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Coronary Pathway Products Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Coronary Pathway Products Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Coronary Pathway Products Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Coronary Pathway Products Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Coronary Pathway Products Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Coronary Pathway Products Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Coronary Pathway Products Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Coronary Pathway Products Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Coronary Pathway Products Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Coronary Pathway Products Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Coronary Pathway Products Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Coronary Pathway Products Market Size Share by Application (2021-2026) Table 24. Global Coronary Pathway Products Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Coronary Pathway Products Market Size Share Forecasted by Application (2027-2032) Table 26. North America Coronary Pathway Products Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Coronary Pathway Products Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Coronary Pathway Products Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Coronary Pathway Products Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Coronary Pathway Products Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Coronary Pathway Products Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Coronary Pathway Products Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Coronary Pathway Products Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Coronary Pathway Products Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Coronary Pathway Products Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Coronary Pathway Products Industry Trends Table 37. Coronary Pathway Products Industry Drivers Table 38. Coronary Pathway Products Industry Opportunities and Challenges Table 39. Coronary Pathway Products Industry Restraints Table 40. Global Coronary Pathway Products Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Coronary Pathway Products Revenue Market Share by Company (2021-2026) Table 42. Global Coronary Pathway Products Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Coronary Pathway Products Key Company Headquarters & Area Served Table 44. Global Coronary Pathway Products Company, Product Type & Application Table 45. Global Coronary Pathway Products Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Coronary Pathway Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Medtronic Company Information Table 49. Medtronic Business Overview Table 50. Medtronic Coronary Pathway Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Medtronic Coronary Pathway Products Product Portfolio Table 52. Medtronic Recent Development Table 53. Terumo Corporation Company Information Table 54. Terumo Corporation Business Overview Table 55. Terumo Corporation Coronary Pathway Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Terumo Corporation Coronary Pathway Products Product Portfolio Table 57. Terumo Corporation Recent Development Table 58. Boston Scientific Company Information Table 59. Boston Scientific Business Overview Table 60. Boston Scientific Coronary Pathway Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Boston Scientific Coronary Pathway Products Product Portfolio Table 62. Boston Scientific Recent Development Table 63. Cordis Company Information Table 64. Cordis Business Overview Table 65. Cordis Coronary Pathway Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Cordis Coronary Pathway Products Product Portfolio Table 67. Cordis Recent Development Table 68. Abbott Company Information Table 69. Abbott Business Overview Table 70. Abbott Coronary Pathway Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Abbott Coronary Pathway Products Product Portfolio Table 72. Abbott Recent Development Table 73. Merit Medical Company Information Table 74. Merit Medical Business Overview Table 75. Merit Medical Coronary Pathway Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Merit Medical Coronary Pathway Products Product Portfolio Table 77. Merit Medical Recent Development Table 78. Curatia Medical Company Information Table 79. Curatia Medical Business Overview Table 80. Curatia Medical Coronary Pathway Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Curatia Medical Coronary Pathway Products Product Portfolio Table 82. Curatia Medical Recent Development Table 83. ASAHI INTECC Company Information Table 84. ASAHI INTECC Business Overview Table 85. ASAHI INTECC Coronary Pathway Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. ASAHI INTECC Coronary Pathway Products Product Portfolio Table 87. ASAHI INTECC Recent Development Table 88. Zhejiang Barty Medical Technology Company Information Table 89. Zhejiang Barty Medical Technology Business Overview Table 90. Zhejiang Barty Medical Technology Coronary Pathway Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Zhejiang Barty Medical Technology Coronary Pathway Products Product Portfolio Table 92. Zhejiang Barty Medical Technology Recent Development Table 93. OrbusNeich Medical Company Company Information Table 94. OrbusNeich Medical Company Business Overview Table 95. OrbusNeich Medical Company Coronary Pathway Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. OrbusNeich Medical Company Coronary Pathway Products Product Portfolio Table 97. OrbusNeich Medical Company Recent Development Table 98. MicroPort Scientific Corporation Company Information Table 99. MicroPort Scientific Corporation Business Overview Table 100. MicroPort Scientific Corporation Coronary Pathway Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. MicroPort Scientific Corporation Coronary Pathway Products Product Portfolio Table 102. MicroPort Scientific Corporation Recent Development Table 103. Suzhou Innomed Medical Device Company Information Table 104. Suzhou Innomed Medical Device Business Overview Table 105. Suzhou Innomed Medical Device Coronary Pathway Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Suzhou Innomed Medical Device Coronary Pathway Products Product Portfolio Table 107. Suzhou Innomed Medical Device Recent Development Table 108. Shunmei Medical Company Information Table 109. Shunmei Medical Business Overview Table 110. Shunmei Medical Coronary Pathway Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Shunmei Medical Coronary Pathway Products Product Portfolio Table 112. Shunmei Medical Recent Development Table 113. Shenzhen MicroApproach Medical Technology Company Information Table 114. Shenzhen MicroApproach Medical Technology Business Overview Table 115. Shenzhen MicroApproach Medical Technology Coronary Pathway Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Shenzhen MicroApproach Medical Technology Coronary Pathway Products Product Portfolio Table 117. Shenzhen MicroApproach Medical Technology Recent Development Table 118. Shanghai INT Medical Instruments Company Information Table 119. Shanghai INT Medical Instruments Business Overview Table 120. Shanghai INT Medical Instruments Coronary Pathway Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Shanghai INT Medical Instruments Coronary Pathway Products Product Portfolio Table 122. Shanghai INT Medical Instruments Recent Development Table 123. Xiamen New Concept Medical Technology Company Information Table 124. Xiamen New Concept Medical Technology Business Overview Table 125. Xiamen New Concept Medical Technology Coronary Pathway Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Xiamen New Concept Medical Technology Coronary Pathway Products Product Portfolio Table 127. Xiamen New Concept Medical Technology Recent Development Table 128. Lepu Medical Technology Company Information Table 129. Lepu Medical Technology Business Overview Table 130. Lepu Medical Technology Coronary Pathway Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Lepu Medical Technology Coronary Pathway Products Product Portfolio Table 132. Lepu Medical Technology Recent Development Table 133. APT Medical Company Information Table 134. APT Medical Business Overview Table 135. APT Medical Coronary Pathway Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. APT Medical Coronary Pathway Products Product Portfolio Table 137. APT Medical Recent Development Table 138. BrosMed Medical Company Information Table 139. BrosMed Medical Business Overview Table 140. BrosMed Medical Coronary Pathway Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. BrosMed Medical Coronary Pathway Products Product Portfolio Table 142. BrosMed Medical Recent Development Table 143. Beijing Demax Medical Technology Company Information Table 144. Beijing Demax Medical Technology Business Overview Table 145. Beijing Demax Medical Technology Coronary Pathway Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Beijing Demax Medical Technology Coronary Pathway Products Product Portfolio Table 147. Beijing Demax Medical Technology Recent Development Table 148. Jiangsu ChangMei Medtech Company Information Table 149. Jiangsu ChangMei Medtech Business Overview Table 150. Jiangsu ChangMei Medtech Coronary Pathway Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Jiangsu ChangMei Medtech Coronary Pathway Products Product Portfolio Table 152. Jiangsu ChangMei Medtech Recent Development Table 153. Jiangxi Hongda Medical Equipment Group Company Information Table 154. Jiangxi Hongda Medical Equipment Group Business Overview Table 155. Jiangxi Hongda Medical Equipment Group Coronary Pathway Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Jiangxi Hongda Medical Equipment Group Coronary Pathway Products Product Portfolio Table 157. Jiangxi Hongda Medical Equipment Group Recent Development Table 158. Changzhou JIUHONG Medical Instrument Company Information Table 159. Changzhou JIUHONG Medical Instrument Business Overview Table 160. Changzhou JIUHONG Medical Instrument Coronary Pathway Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Changzhou JIUHONG Medical Instrument Coronary Pathway Products Product Portfolio Table 162. Changzhou JIUHONG Medical Instrument Recent Development Table 163. North America Coronary Pathway Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. North America Coronary Pathway Products Market Size by Country (2021-2026) & (US$ Million) Table 165. North America Coronary Pathway Products Market Share by Country (2021-2026) Table 166. North America Coronary Pathway Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. North America Coronary Pathway Products Market Share Forecast by Country (2027-2032) Table 168. Europe Coronary Pathway Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Europe Coronary Pathway Products Market Size by Country (2021-2026) & (US$ Million) Table 170. Europe Coronary Pathway Products Market Share by Country (2021-2026) Table 171. Europe Coronary Pathway Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Europe Coronary Pathway Products Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Coronary Pathway Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Coronary Pathway Products Market Size by Country (2021-2026) & (US$ Million) Table 175. Asia-Pacific Coronary Pathway Products Market Share by Country (2021-2026) Table 176. Asia-Pacific Coronary Pathway Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Asia-Pacific Coronary Pathway Products Market Share Forecast by Country (2027-2032) Table 178. Latin America Coronary Pathway Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Latin America Coronary Pathway Products Market Size by Country (2021-2026) & (US$ Million) Table 180. Latin America Coronary Pathway Products Market Share by Country (2021-2026) Table 181. Latin America Coronary Pathway Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Latin America Coronary Pathway Products Market Share Forecast by Country (2027-2032) Table 183. Middle East & Africa Coronary Pathway Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Middle East & Africa Coronary Pathway Products Market Size by Country (2021-2026) & (US$ Million) Table 185. Middle East & Africa Coronary Pathway Products Market Share by Country (2021-2026) Table 186. Middle East & Africa Coronary Pathway Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Middle East & Africa Coronary Pathway Products Market Share Forecast by Country (2027-2032) Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Coronary Pathway Products Product Image Figure 3. Global Coronary Pathway Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Coronary Pathway Products Market Size (2021-2032) & (US$ Million) Figure 5. Global Coronary Pathway Products Market Share by Region: 2025 VS 2032 Figure 6. Global Coronary Pathway Products Market Share by Region (2021-2032) Figure 7. North America Coronary Pathway Products Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Coronary Pathway Products Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Coronary Pathway Products Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Coronary Pathway Products Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Coronary Pathway Products Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Catheter Sheath Set Image Figure 13. Global Catheter Sheath Set Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Arterial Compression Tourniquet Image Figure 15. Global Arterial Compression Tourniquet Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Balloon Dilation Pressure Pump Image Figure 17. Global Balloon Dilation Pressure Pump Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Microcatheter Image Figure 19. Global Microcatheter Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Micro Guide Wire Image Figure 21. Global Micro Guide Wire Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Contrast Catheter Image Figure 23. Global Contrast Catheter Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Contrast Guide Wire Image Figure 25. Global Contrast Guide Wire Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Guiding Catheter Image Figure 27. Global Guiding Catheter Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Y-Shaped Connector Image Figure 29. Global Y-Shaped Connector Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. Others Image Figure 31. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Global Coronary Pathway Products Market Size Overview by Type (2021-2032) & (US$ Million) Figure 33. Global Coronary Pathway Products Market Share by Type 2025 VS 2032 Figure 34. North America Coronary Pathway Products Market Size Share by Type (2021-2032) Figure 35. Europe Coronary Pathway Products Market Size Share by Type (2021-2032) Figure 36. Asia-Pacific Coronary Pathway Products Market Size Share by Type (2021-2032) Figure 37. Latin America Coronary Pathway Products Market Size Share by Type (2021-2032) Figure 38. Middle East and Africa Coronary Pathway Products Market Size Share by Type (2021-2032) Figure 39. Hospital Image Figure 40. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Clinic Image Figure 42. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. Others Image Figure 44. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. Global Coronary Pathway Products Market Size Overview by Application (2021-2032) & (US$ Million) Figure 46. Global Coronary Pathway Products Market Share by Application 2025 VS 2032 Figure 47. North America Coronary Pathway Products Market Size Share by Application (2021-2032) Figure 48. Europe Coronary Pathway Products Market Size Share by Application (2021-2032) Figure 49. Asia-Pacific Coronary Pathway Products Market Size Share by Application (2021-2032) Figure 50. Latin America Coronary Pathway Products Market Size Share by Application (2021-2032) Figure 51. Middle East and Africa Coronary Pathway Products Market Size Share by Application (2021-2032) Figure 52. Global Top 5 and 10 Coronary Pathway Products Players Market Share by Revenue in 2025 Figure 53. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 54. North America Coronary Pathway Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. North America Coronary Pathway Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. North America Coronary Pathway Products Market Share by Country (2021-2032) Figure 57. Europe Coronary Pathway Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Coronary Pathway Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Coronary Pathway Products Market Share by Country (2021-2032) Figure 60. Asia-Pacific Coronary Pathway Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Asia-Pacific Coronary Pathway Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Coronary Pathway Products Market Share by Country (2021-2032) Figure 63. Latin America Coronary Pathway Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Coronary Pathway Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Coronary Pathway Products Market Share by Country (2021-2032) Figure 66. Middle East & Africa Coronary Pathway Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 67. Middle East & Africa Coronary Pathway Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 68. Middle East & Africa Coronary Pathway Products Market Share by Country (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Catheter Sheath Set
  • Arterial Compression Tourniquet
  • Balloon Dilation Pressure Pump
  • Microcatheter
  • Micro Guide Wire
  • Contrast Catheter
  • Contrast Guide Wire
  • Guiding Catheter
  • Y-Shaped Connector
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Medtronic
  • Terumo Corporation
  • Boston Scientific
  • Cordis
  • Abbott
  • Merit Medical
  • Curatia Medical
  • ASAHI INTECC
  • Zhejiang Barty Medical Technology
  • OrbusNeich Medical Company
  • MicroPort Scientific Corporation
  • Suzhou Innomed Medical Device
  • Shunmei Medical
  • Shenzhen MicroApproach Medical Technology
  • Shanghai INT Medical Instruments
  • Xiamen New Concept Medical Technology
  • Lepu Medical Technology
  • APT Medical
  • BrosMed Medical
  • Beijing Demax Medical Technology
  • Jiangsu ChangMei Medtech
  • Jiangxi Hongda Medical Equipment Group
  • Changzhou JIUHONG Medical Instrument

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Coronary Pathway Products Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Coronary Pathway Products Market Size by Region (2021-2032)
  5. 1.4.1 Global Coronary Pathway Products Market Size by Region (2021-2026)
  6. 1.4.2 Global Coronary Pathway Products Market Size by Region (2027-2032)
  7. 1.5 Key Regions Coronary Pathway Products Market Size (2021-2032)
  8. 1.5.1 North America Coronary Pathway Products Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Coronary Pathway Products Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Coronary Pathway Products Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Coronary Pathway Products Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Coronary Pathway Products Market Size Growth Rate (2021-2032)
2 Coronary Pathway Products Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Catheter Sheath Set
  3. 2.1.2 Arterial Compression Tourniquet
  4. 2.1.3 Balloon Dilation Pressure Pump
  5. 2.1.4 Microcatheter
  6. 2.1.5 Micro Guide Wire
  7. 2.1.6 Contrast Catheter
  8. 2.1.7 Contrast Guide Wire
  9. 2.1.8 Guiding Catheter
  10. 2.1.9 Y-Shaped Connector
  11. 2.1.10 Others
  12. 2.2 Global Coronary Pathway Products Market Size by Type
  13. 2.2.1 Global Coronary Pathway Products Market Size Overview by Type (2021-2032)
  14. 2.2.2 Global Coronary Pathway Products Historic Market Size Review by Type (2021-2026)
  15. 2.2.3 Global Coronary Pathway Products Market Size Forecasted by Type (2027-2032)
  16. 2.3 Global Coronary Pathway Products Market Size by Regions
  17. 2.3.1 North America Coronary Pathway Products Market Size Breakdown by Type (2021-2026)
  18. 2.3.2 Europe Coronary Pathway Products Market Size Breakdown by Type (2021-2026)
  19. 2.3.3 Asia-Pacific Coronary Pathway Products Market Size Breakdown by Type (2021-2026)
  20. 2.3.4 South America Coronary Pathway Products Market Size Breakdown by Type (2021-2026)
  21. 2.3.5 Middle East and Africa Coronary Pathway Products Market Size Breakdown by Type (2021-2026)
3 Coronary Pathway Products Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Others
  5. 3.2 Global Coronary Pathway Products Market Size by Application
  6. 3.2.1 Global Coronary Pathway Products Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Coronary Pathway Products Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Coronary Pathway Products Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Coronary Pathway Products Market Size by Regions
  10. 3.3.1 North America Coronary Pathway Products Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Coronary Pathway Products Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Coronary Pathway Products Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Coronary Pathway Products Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Coronary Pathway Products Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Coronary Pathway Products Industry Trends
  2. 4.2 Coronary Pathway Products Industry Drivers
  3. 4.3 Coronary Pathway Products Industry Opportunities and Challenges
  4. 4.4 Coronary Pathway Products Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Coronary Pathway Products Revenue (2021-2026)
  2. 5.2 Global Coronary Pathway Products Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Coronary Pathway Products Key Company Headquarters & Area Served
  4. 5.4 Global Coronary Pathway Products Company, Product Type & Application
  5. 5.5 Global Coronary Pathway Products Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Coronary Pathway Products Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Coronary Pathway Products Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Coronary Pathway Products Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Medtronic
  2. 6.1.1 Medtronic Company Information
  3. 6.1.2 Medtronic Business Overview
  4. 6.1.3 Medtronic Coronary Pathway Products Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Medtronic Coronary Pathway Products Product Portfolio
  6. 6.1.5 Medtronic Recent Developments
  7. 6.2 Terumo Corporation
  8. 6.2.1 Terumo Corporation Company Information
  9. 6.2.2 Terumo Corporation Business Overview
  10. 6.2.3 Terumo Corporation Coronary Pathway Products Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Terumo Corporation Coronary Pathway Products Product Portfolio
  12. 6.2.5 Terumo Corporation Recent Developments
  13. 6.3 Boston Scientific
  14. 6.3.1 Boston Scientific Company Information
  15. 6.3.2 Boston Scientific Business Overview
  16. 6.3.3 Boston Scientific Coronary Pathway Products Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Boston Scientific Coronary Pathway Products Product Portfolio
  18. 6.3.5 Boston Scientific Recent Developments
  19. 6.4 Cordis
  20. 6.4.1 Cordis Company Information
  21. 6.4.2 Cordis Business Overview
  22. 6.4.3 Cordis Coronary Pathway Products Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Cordis Coronary Pathway Products Product Portfolio
  24. 6.4.5 Cordis Recent Developments
  25. 6.5 Abbott
  26. 6.5.1 Abbott Company Information
  27. 6.5.2 Abbott Business Overview
  28. 6.5.3 Abbott Coronary Pathway Products Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Abbott Coronary Pathway Products Product Portfolio
  30. 6.5.5 Abbott Recent Developments
  31. 6.6 Merit Medical
  32. 6.6.1 Merit Medical Company Information
  33. 6.6.2 Merit Medical Business Overview
  34. 6.6.3 Merit Medical Coronary Pathway Products Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Merit Medical Coronary Pathway Products Product Portfolio
  36. 6.6.5 Merit Medical Recent Developments
  37. 6.7 Curatia Medical
  38. 6.7.1 Curatia Medical Company Information
  39. 6.7.2 Curatia Medical Business Overview
  40. 6.7.3 Curatia Medical Coronary Pathway Products Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Curatia Medical Coronary Pathway Products Product Portfolio
  42. 6.7.5 Curatia Medical Recent Developments
  43. 6.8 ASAHI INTECC
  44. 6.8.1 ASAHI INTECC Company Information
  45. 6.8.2 ASAHI INTECC Business Overview
  46. 6.8.3 ASAHI INTECC Coronary Pathway Products Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 ASAHI INTECC Coronary Pathway Products Product Portfolio
  48. 6.8.5 ASAHI INTECC Recent Developments
  49. 6.9 Zhejiang Barty Medical Technology
  50. 6.9.1 Zhejiang Barty Medical Technology Company Information
  51. 6.9.2 Zhejiang Barty Medical Technology Business Overview
  52. 6.9.3 Zhejiang Barty Medical Technology Coronary Pathway Products Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Zhejiang Barty Medical Technology Coronary Pathway Products Product Portfolio
  54. 6.9.5 Zhejiang Barty Medical Technology Recent Developments
  55. 6.10 OrbusNeich Medical Company
  56. 6.10.1 OrbusNeich Medical Company Company Information
  57. 6.10.2 OrbusNeich Medical Company Business Overview
  58. 6.10.3 OrbusNeich Medical Company Coronary Pathway Products Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 OrbusNeich Medical Company Coronary Pathway Products Product Portfolio
  60. 6.10.5 OrbusNeich Medical Company Recent Developments
  61. 6.11 MicroPort Scientific Corporation
  62. 6.11.1 MicroPort Scientific Corporation Company Information
  63. 6.11.2 MicroPort Scientific Corporation Business Overview
  64. 6.11.3 MicroPort Scientific Corporation Coronary Pathway Products Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 MicroPort Scientific Corporation Coronary Pathway Products Product Portfolio
  66. 6.11.5 MicroPort Scientific Corporation Recent Developments
  67. 6.12 Suzhou Innomed Medical Device
  68. 6.12.1 Suzhou Innomed Medical Device Company Information
  69. 6.12.2 Suzhou Innomed Medical Device Business Overview
  70. 6.12.3 Suzhou Innomed Medical Device Coronary Pathway Products Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Suzhou Innomed Medical Device Coronary Pathway Products Product Portfolio
  72. 6.12.5 Suzhou Innomed Medical Device Recent Developments
  73. 6.13 Shunmei Medical
  74. 6.13.1 Shunmei Medical Company Information
  75. 6.13.2 Shunmei Medical Business Overview
  76. 6.13.3 Shunmei Medical Coronary Pathway Products Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Shunmei Medical Coronary Pathway Products Product Portfolio
  78. 6.13.5 Shunmei Medical Recent Developments
  79. 6.14 Shenzhen MicroApproach Medical Technology
  80. 6.14.1 Shenzhen MicroApproach Medical Technology Company Information
  81. 6.14.2 Shenzhen MicroApproach Medical Technology Business Overview
  82. 6.14.3 Shenzhen MicroApproach Medical Technology Coronary Pathway Products Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Shenzhen MicroApproach Medical Technology Coronary Pathway Products Product Portfolio
  84. 6.14.5 Shenzhen MicroApproach Medical Technology Recent Developments
  85. 6.15 Shanghai INT Medical Instruments
  86. 6.15.1 Shanghai INT Medical Instruments Company Information
  87. 6.15.2 Shanghai INT Medical Instruments Business Overview
  88. 6.15.3 Shanghai INT Medical Instruments Coronary Pathway Products Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Shanghai INT Medical Instruments Coronary Pathway Products Product Portfolio
  90. 6.15.5 Shanghai INT Medical Instruments Recent Developments
  91. 6.16 Xiamen New Concept Medical Technology
  92. 6.16.1 Xiamen New Concept Medical Technology Company Information
  93. 6.16.2 Xiamen New Concept Medical Technology Business Overview
  94. 6.16.3 Xiamen New Concept Medical Technology Coronary Pathway Products Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Xiamen New Concept Medical Technology Coronary Pathway Products Product Portfolio
  96. 6.16.5 Xiamen New Concept Medical Technology Recent Developments
  97. 6.17 Lepu Medical Technology
  98. 6.17.1 Lepu Medical Technology Company Information
  99. 6.17.2 Lepu Medical Technology Business Overview
  100. 6.17.3 Lepu Medical Technology Coronary Pathway Products Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Lepu Medical Technology Coronary Pathway Products Product Portfolio
  102. 6.17.5 Lepu Medical Technology Recent Developments
  103. 6.18 APT Medical
  104. 6.18.1 APT Medical Company Information
  105. 6.18.2 APT Medical Business Overview
  106. 6.18.3 APT Medical Coronary Pathway Products Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 APT Medical Coronary Pathway Products Product Portfolio
  108. 6.18.5 APT Medical Recent Developments
  109. 6.19 BrosMed Medical
  110. 6.19.1 BrosMed Medical Company Information
  111. 6.19.2 BrosMed Medical Business Overview
  112. 6.19.3 BrosMed Medical Coronary Pathway Products Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 BrosMed Medical Coronary Pathway Products Product Portfolio
  114. 6.19.5 BrosMed Medical Recent Developments
  115. 6.20 Beijing Demax Medical Technology
  116. 6.20.1 Beijing Demax Medical Technology Company Information
  117. 6.20.2 Beijing Demax Medical Technology Business Overview
  118. 6.20.3 Beijing Demax Medical Technology Coronary Pathway Products Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Beijing Demax Medical Technology Coronary Pathway Products Product Portfolio
  120. 6.20.5 Beijing Demax Medical Technology Recent Developments
  121. 6.21 Jiangsu ChangMei Medtech
  122. 6.21.1 Jiangsu ChangMei Medtech Company Information
  123. 6.21.2 Jiangsu ChangMei Medtech Business Overview
  124. 6.21.3 Jiangsu ChangMei Medtech Coronary Pathway Products Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Jiangsu ChangMei Medtech Coronary Pathway Products Product Portfolio
  126. 6.21.5 Jiangsu ChangMei Medtech Recent Developments
  127. 6.22 Jiangxi Hongda Medical Equipment Group
  128. 6.22.1 Jiangxi Hongda Medical Equipment Group Company Information
  129. 6.22.2 Jiangxi Hongda Medical Equipment Group Business Overview
  130. 6.22.3 Jiangxi Hongda Medical Equipment Group Coronary Pathway Products Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Jiangxi Hongda Medical Equipment Group Coronary Pathway Products Product Portfolio
  132. 6.22.5 Jiangxi Hongda Medical Equipment Group Recent Developments
  133. 6.23 Changzhou JIUHONG Medical Instrument
  134. 6.23.1 Changzhou JIUHONG Medical Instrument Company Information
  135. 6.23.2 Changzhou JIUHONG Medical Instrument Business Overview
  136. 6.23.3 Changzhou JIUHONG Medical Instrument Coronary Pathway Products Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Changzhou JIUHONG Medical Instrument Coronary Pathway Products Product Portfolio
  138. 6.23.5 Changzhou JIUHONG Medical Instrument Recent Developments
7 North America
  1. 7.1 North America Coronary Pathway Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Coronary Pathway Products Market Size by Country (2021-2026)
  3. 7.3 North America Coronary Pathway Products Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Coronary Pathway Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Coronary Pathway Products Market Size by Country (2021-2026)
  3. 8.3 Europe Coronary Pathway Products Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Coronary Pathway Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Coronary Pathway Products Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Coronary Pathway Products Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Coronary Pathway Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Coronary Pathway Products Market Size by Country (2021-2026)
  3. 10.3 South America Coronary Pathway Products Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Coronary Pathway Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Coronary Pathway Products Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Coronary Pathway Products Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research